Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CVR Chicago Rivet & Machine

Trading 04-02 14:29:38 EDT

11.28

+0.78

+7.43%

High11.28	Low10.25	Vol5.12K
Open10.25	D1 Closing10.50	Amplitude9.81%
Mkt Cap10.90M	Tradable Cap8.27M	Total Shares966.13K
T/O54.99K	T/O Rate0.70%	Tradable Shares733.35K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"CVR","market":"US","secType":"STK","nameCN":"Chicago Rivet & Machine","latestPrice":11.28,"timestamp":1743618440652,"preClose":10.5,"halted":0,"volume":5115,"delay":0,"floatShares":733351,"shares":966132,"eps":-5.81247,"marketStatus":"Trading","change":0.78,"latestTime":"04-02 14:29:38 EDT","open":10.25,"high":11.28,"low":10.25,"amount":54985.569705,"amplitude":0.098095,"askPrice":11.46,"askSize":2,"bidPrice":10.24,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-5.81247,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743624000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":10.5,"dividendRate":0.029255,"preHourTrading":{"tag":"盘前","latestPrice":10.2,"preClose":10.5,"latestTime":"04:50 EDT","volume":5,"amount":55.25,"timestamp":1743583838168},"postHourTrading":{"tag":"盘后","latestPrice":10.5,"preClose":10.5,"latestTime":"17:41 EDT","volume":3,"amount":31.76,"timestamp":1743543715817},"volumeRatio":1.228931},"requestUrl":"/m/hq/s/CVR/wiki","defaultTab":"wiki","newsList":[{"id":"2524111850","title":"CVR Energy price target raised to $21 from $20 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2524111850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524111850?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:56","pubTimestamp":1743508571,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on CVR Energy (CVI) to $21 from $20 and keeps a Neutral rating on the shares. The firm expects the company to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvr-energy-price-target-raised-to-21-from-20-at-mizuho?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvr-energy-price-target-raised-to-21-from-20-at-mizuho?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","CVR"],"gpt_icon":0},{"id":"2524974624","title":"Press Release: Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974624","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974624?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Emrosi approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled. Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; Checkpoint's lead product, UNLOXCYT, approved by FDA for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma. FDA accepted New Drug Application filing for priority review for CUTX-101 to treat Menkes disease; PDUFA goal date of September 30, 2025. Dr. Rosenwald continued, \"Looking ahead, we are focused on our next key milestone: the September 30, 2025, Prescription Drug User Fee Act  goal date for CUTX-101. Upon approval of the New Drug Application, our majority-owned subsidiary, Cyprium Therapeutics, may be eligible for a Priority Review Voucher. The commercial launch of Emrosi for inflammatory lesions of rosacea is underway with first prescriptions filled, and we expect continued revenue growth, portfoli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","03160","BK4232","BK4022","BK4604","CVR","BK4161","R","BK4139","FBIO","BK4585","TM","BK4588","BK4099"],"gpt_icon":0},{"id":"2523672249","title":"Reported Friday, Chicago Rivet & Machine 2024 EPS $(5.81) Down From $(4.56) YoY, Revenue $26.99M Down From $31.51M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2523672249","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523672249?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 15:55","pubTimestamp":1743407711,"startTime":"0","endTime":"0","summary":"Reported Friday, Chicago Rivet & Machine 2024 EPS $(5.81) Down From $(4.56) YoY, Revenue $26.99M Down From $31.51M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44555721/reported-friday-chicago-rivet-machine-2024-eps-5-81-down-from-4-56-yoy-revenue-26-99m-down-from-31-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR"],"gpt_icon":0},{"id":"2523632266","title":"Press Release: Chicago Rivet & Machine Co. Announces Year-End Results of Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2523632266","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523632266?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 07:02","pubTimestamp":1743202920,"startTime":"0","endTime":"0","summary":"NAPERVILLE, Ill., March 28, 2025 /PRNewswire/ -- Chicago Rivet & Machine Co.  today announced audited results for the year 2024 as summarized below:","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","CVR"],"gpt_icon":0},{"id":"2522581108","title":"CVR Energy Is Maintained at Sell by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2522581108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522581108?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 00:38","pubTimestamp":1743093480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CVI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 12:38 ET (16:38 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","CVI"],"gpt_icon":0},{"id":"2522706547","title":"CVR Energy, Inc. (CVI): Among Stocks Receiving the Most Insider Investment in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2522706547","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522706547?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 02:08","pubTimestamp":1742839730,"startTime":"0","endTime":"0","summary":"We recently published a list of Insiders Are Spending Big: 15 Stocks Leading in March. In this article, we are going to take a look at where CVR Energy, Inc.  stands against other stocks that are receiving the most insider investment in March.“The economy is strong overall and has made significant progress toward our goals over the past two years,” Federal Reserve Chair Jerome Powell said during a press conference Wednesday following the decision announcement. “Labor market conditions are solid, and inflation has moved closer to our 2% longer-run goal, though it remains somewhat elevated.”The Fed announced on Wednesday that it would maintain the federal funds rate at its current range of 4.25% to 4.5%. It is also keeping its outlook at two rate cuts for the remainder of this year, writes CNBC.However, the Fed also announced that “uncertainty around the economic outlook has increased.”However, insider selling doesn’t always signal a lack of faith—it may be due to personal financial need","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvr-energy-inc-cvi-among-180850969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US6M.BOND","US7Y.BOND","US30Y.BOND","BK4138","CVI","US2Y.BOND","US10Y.BOND","BK4161","US12M.BOND","US3Y.BOND","CVR","US5Y.BOND"],"gpt_icon":0},{"id":"2521373482","title":"Carl Icahn's Strategic Acquisition of CVR Energy Inc. Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2521373482","media":"GuruFocus","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521373482?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 23:01","pubTimestamp":1742569319,"startTime":"0","endTime":"0","summary":"On March 12, 2025, Carl Icahn (Trades, Portfolio), a prominent activist investor, executed a significant transaction involving CVR Energy Inc. The firm added 295,221 shares to its holdings at a price ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2745456/carl-icahns-strategic-acquisition-of-cvr-energy-inc-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["BK4138","CVR","BK4161","CVI"],"gpt_icon":0},{"id":"2520061728","title":"Acelyrin, Inc. (SLRN): One of the Best Short-Term Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2520061728","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520061728?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 16:46","pubTimestamp":1742287581,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at where Acelyrin, Inc.  stands against other best short-term stocks with a buying opportunity for investors.Thrilling highs, daunting lows, and the energized chase after the next big opportunity – this thoroughly defines the current stock market. In this roller coaster ride, momentum investing is an often-seen strategy piquing the investors’ interest, which involves capitalizing on continuing existing market trends. The approach holds onto the hope that high performers in the past will continue to perform better in the future as well. A curious subset within the strategy is the price momentum stocks, whose recent downturns are seen as an opportunity as they show potential for a swift rebound.READ ALSO:12 Best Multibagger Stocks to Buy in 2025. The pursuit of high returns can be tempting. Hence, investors are suggested to estimate the risk tolerance levels and long-t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acelyrin-inc-slrn-one-best-084621773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139",".IXIC","MNQmain","NQmain","QID","SLRN","PSQ","CVR","TQQQ","NVIW.SI","SQQQ","USJW.SI","BK4161","USAW.SI","QLD","TSYW.SI"],"gpt_icon":1},{"id":"2520683298","title":"Press Release: XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements","url":"https://stock-news.laohu8.com/highlight/detail?id=2520683298","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520683298?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 04:30","pubTimestamp":1742243400,"startTime":"0","endTime":"0","summary":"XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements. Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in 2024. Completed two whole company acquisitions to unlock shareholder value. Day One's OJEMDA  and Zevra's MIPLYFFA  each received FDA approval. Cash receipts totaled $4.0 million in the fourth quarter and $46.3 million for the full year 2024. EMERYVILLE, Calif., March 17, 2025  -- XOMA Royalty Corporation , the biotech royalty aggregator, reported its fourth quarter and full year 2024 financial results and highlighted recent activities.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","XOMA","BK4585","03160","BK4588","BK4139","BK4099","BK4604","R","BK4022","BK4232","BK4555","TM","CVR"],"gpt_icon":0},{"id":"2519348880","title":"Stocks have fallen, but wait for these signals before deciding it's time to buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2519348880","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519348880?lang=en_us&edition=full_marsco","pubTime":"2025-03-16 02:11","pubTimestamp":1742062260,"startTime":"0","endTime":"0","summary":"The S&P 500 Index SPX continues to fall and has broken through all of the support levels that were in place. Most important, it has broken below the trading range that had been in place since last November. There is tentative support at this week's lows, near 5,525. There also may be support at last September's lows, at 5,400.The U.S. market currently is quite oversold, but oversold does not mean \"buy.\" Rather, we are still waiting on confirmed buy signals, which for the most part have been evasive. Oversold rallies can be strong initially but generally fade out when they reach the declining 20-day moving average, which is currently at 5,900 and falling quickly. Still, that would suggest a 300-point rally once it gets underway.The Cboe Volatility Index VIX continues to trend higher, and thus the trend of VIX sell signal remains in place. Its inception is marked with a circle on the accompanying VIX chart on the lower right. Contrasting that to a certain extent is the fact that yet anot","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVIX","SG9999014906.USD","SG9999018865.SGD","IE00BZ199S13.USD","VIXY","WBA","LU2272731865.HKD","CVR","ALL","BK4550","SG9999014914.USD","BK4512","IE00BQXX3F31.USD","BK4585","OEX","VXX","LU1244550577.SGD","LU2355687059.USD","APH","SPXU","UVXY","LU1992135399.USD","LU2272731782.SGD","VOO","IE00BQXX3C00.GBP","BK4559","BK4588","SSO","LU2322448957.HKD","ESmain","LU1992135472.HKD","LU1571399168.USD","LU1699723380.USD","SPY","SG9999014880.SGD","VIXmain",".SPX","SVXY","IVV","IE00BQXX3D17.EUR","SH","SG9999018857.SGD","IE00B5TLWC47.USD","OEF","BK4581","LU0321505439.SGD","LU0321505868.SGD","SDS"],"gpt_icon":1},{"id":"2519486568","title":"Stock investors are leaping before they look as market uncertainty takes a toll","url":"https://stock-news.laohu8.com/highlight/detail?id=2519486568","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519486568?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 03:16","pubTimestamp":1741893360,"startTime":"0","endTime":"0","summary":"S&P 500 is in correction territory, and buyers are scarce. The S&P 500 Index SPX continues to fall and has broken through all of the support levels that were in place. Most important, it has broken below the trading range that had been in place since last November. There is tentative support at this week's lows, near 5,525. There also may be support at last September's lows, at 5,400.The U.S. market currently is quite oversold, but oversold does not mean \"buy.\" Rather, we are still waiting on confirmed buy signals, which for the most part have been evasive. Oversold rallies can be strong initially but generally fade out when they reach the declining 20-day moving average, which is currently at 5,900 and falling quickly. Still, that would suggest a 300-point rally once it gets underway.The Cboe Volatility Index VIX continues to trend higher, and thus the trend of VIX sell signal remains in place. Its inception is marked with a circle on the accompanying VIX chart on the lower right. Con","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ199S13.USD","SG9999017495.SGD","LU1992135472.HKD","VIXmain","BK4581","SPXU","SPY","SVXY","TVIX","LU2272731865.HKD","LU2322448791.USD","LU1244550221.USD","VOO","SGXZ31699556.SGD","LU1244550494.USD","SG9999014906.USD","VXX","BK4550","ESmain","SDS","SSO","UVXY","LU1992135399.USD","BK4534","IVV","ALL","BK4148","SH","VIXY","OEF","IE00BFXG0V08.USD","LU2272731782.SGD","SG9999014880.SGD","BK4512","LU2322448957.HKD","CVR","IE00BYQQ9H92.USD","LU1571399168.USD","SG9999018857.SGD","LU0321505868.SGD","APH","BK4161",".SPX","LU2272731600.USD","WBA","OEX","IE00B5TLWC47.USD","IE00BQXX3D17.EUR"],"gpt_icon":1},{"id":"2518737889","title":"Carl Icahn Makes a Bold Move with New CVR Partners Stock Purchase!","url":"https://stock-news.laohu8.com/highlight/detail?id=2518737889","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518737889?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 10:07","pubTimestamp":1741658848,"startTime":"0","endTime":"0","summary":"New insider activity at CVR Partners ( ($UAN) ) has taken place on March 11, 2025. Significant shareholder Carl Icahn has made a notable investment...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/carl-icahn-makes-a-bold-move-with-new-cvr-partners-stock-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/carl-icahn-makes-a-bold-move-with-new-cvr-partners-stock-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2518202297","title":"23andMe's Wild Ride: From $6 Billion to Wojcicki's Buyout Gamble--Will Investors Get Screwed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202297","media":"GuruFocus.com","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518202297?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 03:41","pubTimestamp":1741635684,"startTime":"0","endTime":"0","summary":"23andMe  is back in the spotlight as CEO Anne Wojcicki makes yet another play to take the struggling genetic testing company private. After her previous lowball offer of $0.41 per share was swiftly rejected, Wojcicki returned with a revised bid of $2.94 per share, including a contingent value right . The latest proposal follows a turbulent period where 23andMe's valuation cratered from $6 billion just a few years ago to near penny-stock status. Wojcicki, who controls nearly half the company's voting power, has faced mounting criticism over governance concerns, particularly after a mass board resignation left her handpicking the company's current leadership.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/23andmes-wild-ride-6-billion-194124114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","CVR","BK4161","BK4196","ISBC","ME","BK4211"],"gpt_icon":0},{"id":"2518272614","title":"India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272614","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272614?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 23:08","pubTimestamp":1741619331,"startTime":"0","endTime":"0","summary":"On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc.  for an upfront cash payment of$4.10/share.In December, the FDA approvedCheckpoint Therapeutics’ Unloxcyt for metastatic cutaneous squamous cell carcinoma  or locally advanced cSCC who are not candidates for curativesurgery or curative radiation.Unloxcyt is the first and only programmed death ligand-1  blocking antibody to receive FDA marketing approval for this indication.The recommended commercial dosage of Unloxcyt is 1,200 mg administered as an intravenous infusion over 60 minutes every three weeks.Stockholders will receive a non-transferable contingent value right  of up to an additional$0.70/share in cash if cosibelimab is approved before certain deadlines in the European Union pursuant to the centralized approval procedure or inGermany,France,Italy,Spainor theUnited Kingdom.In connection with the transaction, Fortress","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/india-based-sun-pharma-buy-150851023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CKPT","FBIO","BK4161","BK4139","LENZ","CVR"],"gpt_icon":0},{"id":"2518251137","title":"Sun Pharma to Acquire Checkpoint Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2518251137","media":"PR Newswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518251137?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 10:06","pubTimestamp":1741572360,"startTime":"0","endTime":"0","summary":"Will add UNLOXCYT , the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma  to Sun Pharma's global onco-derm franchise. Upfront cash payment of $4.10 per share of common stock,representing aggregate upfront consideration of up to $355 million. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for patients with solid tumor cancers. Checkpoint has received approval from the U.S. Food & Drug Administration  for UNLOXCYT for the treatment of adults with metastatic cutaneous squamous cell carcinoma  or locally advanced cSCC who are not candidates for curative surgery or curative radiation.Upon completion of the transaction, Sun Pharma will acquire all outstanding shares of Checkpoint and Checkpoint stockholders will receive, for each share of common stock they hold, an upfront cash payment of $4.10, without interest, and a non-transferable contingent value right  entitling the stoc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/sun-pharma-acquire-checkpoint-therapeutics-020600240.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sun-pharma-acquire-checkpoint-therapeutics-020600240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HSCT","BK4161","BK4144","LENZ","TEN","FBIO","CKPT","FBIOP","BK4124","CVR","BK4139"],"gpt_icon":0},{"id":"2517617136","title":"Carl Icahn Increases Stake in CVR Partners LP with Recent Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2517617136","media":"GuruFocus","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517617136?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 14:05","pubTimestamp":1741241126,"startTime":"0","endTime":"0","summary":"Recent Transaction Details On March 5, 2025, Carl Icahn (Trades, Portfolio) executed a strategic stock transaction involving CVR Partners LP, a prominent player in the nitrogen fertilizer industry. Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2729889/carl-icahn-increases-stake-in-cvr-partners-lp-with-recent-acquisition","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["CVR","UAN","BK4093","BK4161","BK4590"],"gpt_icon":0},{"id":"2517422990","title":"CVR Energy, Inc. (CVI): Among Stocks With At Least $10 Million In Insider Spending Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2517422990","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517422990?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 19:06","pubTimestamp":1741172778,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are going to take a look at where CVR Energy, Inc.  stands against other stocks with at least $10 million in insider spending recently.Since Donald Trump took office, the stock market has experienced a roller coaster ride. Nonetheless, despite concerns about tariffs, job cuts, policy changes, and geopolitical uncertainties, the broader market has risen by 1.46% year-to-date. Furthermore, equity strategists in a Reuters poll project that the broader market will finish the year 9% higher than its current level.“Many analysts agree with this projection, arguing that the Trump administration’s policies won’t have long-term negative impacts on economic growth or inflation. Furthermore, Trump is often considered the most pro-stock market president in American history.Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge fu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvr-energy-inc-cvi-among-110618878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4138","CVI","CVR","BK4161"],"gpt_icon":0},{"id":"2517957366","title":"Carl Icahn's Strategic Acquisition in CVR Energy Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517957366","media":"GuruFocus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517957366?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 11:40","pubTimestamp":1741146009,"startTime":"0","endTime":"0","summary":"On March 4, 2025, Carl Icahn (Trades, Portfolio), a prominent activist investor, executed a significant transaction involving CVR Energy Inc. The firm added 377,260 shares to its holdings at a price o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2727873/carl-icahns-strategic-acquisition-in-cvr-energy-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["BK4138","BK4161","CVI","CVR"],"gpt_icon":0},{"id":"2516661964","title":"CVR Energy Unveils New Investor Presentation for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661964?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 05:53","pubTimestamp":1741038793,"startTime":"0","endTime":"0","summary":"CVR Energy ( ($CVI) ) has issued an announcement. CVR Energy, Inc. announced that starting March 3, 2025, it will use a new Investor Presentation c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvr-energy-unveils-new-investor-presentation-for-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvr-energy-unveils-new-investor-presentation-for-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4161","CVR"],"gpt_icon":0},{"id":"2516255717","title":"CVR Energy, Inc. (CVI): Among Top Stock Picks From Carl Icahn’s Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2516255717","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516255717?lang=en_us&edition=full_marsco","pubTime":"2025-03-02 00:27","pubTimestamp":1740846473,"startTime":"0","endTime":"0","summary":"We recently published a list of Carl Icahn Stock Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where CVR Energy, Inc.  stands against other top stock picks from Carl Icahn's portfolio.Billionaire hedge fund manager Carl Icahn was known as a corporate raider in the 1980s, although he is now more commonly referred to as an activist investor. Icahn is a relentless and self-consciously contrarian investor with a keen eye for undervalued opportunities. Valuing hard assets, he has often stated that he prefers to purchase unglamorous, out-of-favor companies. The same is true for his investment wheel,Icahn Capital LP, which is well-known for its aggressive and high-stakes activism efforts, establishing itself as one of the world’s most powerful and prominent hedge funds. Boasting an impressive track record, the billionaire investor achieved an average annualized return of 14% between 2000 and 2022, outperforming the S&P 500 by 6%.Why are we interested in the st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvr-energy-inc-cvi-among-162753360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4138","CVR","BK4161","CVI","IEP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chicagorivet.com","stockEarnings":[{"period":"1week","weight":-0.2135},{"period":"1month","weight":-0.2759},{"period":"3month","weight":-0.3371},{"period":"6month","weight":-0.4167},{"period":"1year","weight":-0.3824},{"period":"ytd","weight":-0.3371}],"compareEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0121},{"period":"1year","weight":0.0743},{"period":"ytd","weight":-0.0428}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Chicago Rivet & Machine Co. operates in the fastener industry in North America. The company operates in two segments, Fasteners and Assembly Equipment. The Fastener segment manufactures and sells rivets, cold-formed fasteners and parts, and screw machine products. The Assembly Equipment segment manufactures and sells automatic rivet setting machines and assembly equipment, as well as parts and tools for related machines. It sells its products to automobile and automotive component manufacturers through independent sales representatives. The company was founded in 1920 and is headquartered in Naperville, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.755556,"avgChangeRate":0.045711},{"month":2,"riseRate":0.688889,"avgChangeRate":0.020881},{"month":3,"riseRate":0.4,"avgChangeRate":0.012556},{"month":4,"riseRate":0.456522,"avgChangeRate":-0.00141},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.004472},{"month":6,"riseRate":0.422222,"avgChangeRate":-0.003417},{"month":7,"riseRate":0.488889,"avgChangeRate":0.01474},{"month":8,"riseRate":0.377778,"avgChangeRate":-0.011647},{"month":9,"riseRate":0.4,"avgChangeRate":-0.006018},{"month":10,"riseRate":0.488889,"avgChangeRate":0.005387},{"month":11,"riseRate":0.355556,"avgChangeRate":-0.005106},{"month":12,"riseRate":0.4,"avgChangeRate":-0.021494}],"exchange":"AMEX","name":"Chicago Rivet & Machine","nameEN":"Chicago Rivet & Machine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Chicago Rivet & Machine(CVR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Chicago Rivet & Machine,CVR,Chicago Rivet & Machine股票,Chicago Rivet & Machine股票老虎,Chicago Rivet & Machine股票老虎国际,Chicago Rivet & Machine行情,Chicago Rivet & Machine股票行情,Chicago Rivet & Machine股价,Chicago Rivet & Machine股市,Chicago Rivet & Machine股票价格,Chicago Rivet & Machine股票交易,Chicago Rivet & Machine股票购买,Chicago Rivet & Machine股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chicago Rivet & Machine(CVR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Chicago Rivet & Machine(CVR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction